Hydrogen sulfide improves resuscitation via non-hibernatory mechanisms in a porcine shock model.

Abstract

BACKGROUND:

Hydrogen sulfide (H2S) has been demonstrated to induce a "suspended animation-like" state in rodent models by reversible inhibition of cellular respiration and marked metabolic suppression and has been proposed as a potential pharmacologic adjunct to resuscitation from shock states. There are few data currently available about the mechanisms and efficacy of H2S in larger animals or humans. We examined H2S as a pharmacologic adjunct to resuscitation in a porcine model of severe traumatic shock.

METHODS:

Twenty-one adult swine were assigned to three study arms: sham, H2S, and saline vehicle controls (SC). All pigs underwent laparotomy and instrumentation, and the two study arms then underwent a 35% controlled hemorrhage followed by 50 min of truncal ischemia via aortic cross-clamp. H2S (5 mg/kg) or saline was administered immediately before reperfusion, followed by 6 h of resuscitation. Resuscitation requirements, laboratory parameters, end-organ histology, and inflammatory product gene expression (by reverse transcription-polymerase chain reaction) were measured and compared between groups.

RESULTS:

All animals survived to the 6-h postresuscitation time point. Both treatment arms demonstrated severe shock characterized by fluid and vasopressor requirements, metabolic acidosis, and hypotension compared with sham animals. Animals treated with H2S demonstrated significantly lower resuscitative requirements (total epinephrine 727 versus 3052 μg; P < 0.05), decreased fluid requirements, and lower serum lactate levels (7 versus 10 mmol/L) versus SC. Cardiac output was slightly decreased with H2S treatment but all other hemodynamic and metabolic parameters were equivalent between H2S and C groups. Serum liver and kidney biomarkers were unchanged, but administration of H2S was associated with a significant improvement in histopathologic liver and kidney injury scores compared with SC (both P < 0.05). Both study groups demonstrated significantly increased gene expression of hypoxia-inducible factor 1α and nitric oxide synthase (endogenous nitric oxide synthase, inducible nitric oxide synthase [iNOS]2, iNOS3) relative to sham animals. However, H2S was associated with increased expression of hypoxia-inducible factor 1α and decreased iNOS2 levels compared with SC.

CONCLUSIONS:

Administration of H2S in a large-animal model of severe traumatic shock resulted in a significant decrease in resuscitative requirements, decreased metabolic acidosis, and less end-organ histologic injury compared with standard resuscitation. H2S did not induce profound metabolic suppression as seen in rodents, and appears to have alternative mechanisms of action in large animals.

• Authors: Steven A Satterly, Shashikumar Salgar, Zachary Hoffer, James Hempel, Mary J DeHart, Mark Wingerd, Huang Raywin, Jonathan D Stallings, Matthew Martin
• Journal: The Journal of surgical research (J Surg Res) Vol. 199 Issue 1 Pg. 197-210 (Nov 2015) ISSN: 1095-8673 [Electronic] United States
• PMID: 25956183 (Publication Type: Evaluation Study, Journal Article)
• Copyright: Published by Elsevier Inc.

Chemical References

• Biomarkers
• Protective Agents
• Hydrogen Sulfide

Topics

• Acidosis (etiology, prevention & control)
• Animals
• Biomarkers (metabolism)
• Cardiac Output (drug effects)
• Combined Modality Therapy
• Homeostasis (drug effects)
• Hydrogen Sulfide (pharmacology, therapeutic use)
• Male
• Multiple Organ Failure (etiology, prevention & control)
• Protective Agents (pharmacology, therapeutic use)
• Resuscitation (methods)
• Shock, Hemorrhagic (metabolism, physiopathology, therapy)
• Swine